Immediate Treatment for Nut-Induced Anaphylaxis
Administer intramuscular epinephrine immediately into the anterolateral thigh—this is the single most critical intervention that saves lives, and delayed administration is directly linked to fatal outcomes. 1, 2
First-Line Treatment: Epinephrine
Epinephrine is the only first-line treatment for anaphylaxis and must never be delayed. 1, 3
Dosing Protocol
- Weight 10-25 kg: 0.15 mg IM via autoinjector into anterolateral thigh 1, 4
- Weight >25 kg: 0.3 mg IM via autoinjector into anterolateral thigh 1, 4
- Alternative dosing: 0.01 mg/kg (maximum 0.5 mg) if using 1:1000 solution 1, 3
- Repeat doses: May be required every 5-15 minutes as needed 1
- Multiple doses needed: Approximately 19% of pediatric food-induced anaphylaxis cases require more than one dose of epinephrine 5
Critical Administration Details
- Site matters: Always inject into the anterolateral thigh, never into buttocks, digits, hands, or feet 3
- Route matters: Intramuscular administration is superior to subcutaneous for anaphylaxis 3, 6
- Timing is everything: Peanuts and tree nuts cause the majority of fatal food-induced anaphylaxis, and fatalities are specifically associated with delayed or improper epinephrine dosing 1, 2
Adjunctive Treatments (After Epinephrine)
These treatments occur concomitantly but should never replace or delay epinephrine administration: 1, 2
Immediate Adjuncts
- Albuterol (β2-agonist): MDI 4-8 puffs (child) or 8 puffs (adult), OR nebulized 1.5 mL (child) or 3 mL (adult) every 20 minutes or continuously 1
- Diphenhydramine (H1-antihistamine): 1-2 mg/kg per dose, maximum 50 mg IV or oral (oral liquid absorbs faster than tablets) 1
- Supplemental oxygen: Administer as needed 1
- IV fluids: Large volumes if patient has orthostasis, hypotension, or incomplete response to epinephrine 1
- Patient positioning: Recumbent with lower extremities elevated if tolerated 1
Hospital-Based Additional Adjuncts
- Ranitidine (H2-antihistamine): 1-2 mg/kg per dose, maximum 75-150 mg 1
- Corticosteroids: Prednisone 1 mg/kg (maximum 60-80 mg) or methylprednisolone 1
- Continuous epinephrine infusion: Consider for persistent hypotension with continuous monitoring 1
Observation Period
All patients who receive epinephrine must be transferred to an emergency facility for observation. 1
- Standard observation: 4-6 hours minimum for most patients 1, 4
- Extended observation or admission: Required for severe/refractory symptoms, history of biphasic reactions, coexisting severe asthma, cardiovascular disease, or delayed epinephrine administration 4, 6
- Biphasic reaction risk: Occurs in 1-20% of cases, typically around 8 hours but can occur up to 72 hours later 1, 4
Discharge Requirements
Every patient must leave with all five components: 1, 2, 4
1. Epinephrine Autoinjectors
- Prescribe two doses to carry at all times 2, 4
- Provide hands-on training in proper use before discharge 4
- Establish plan for monitoring expiration dates 1, 4
2. Written Emergency Action Plan
- Detail trigger avoidance strategies 2, 4
- Include early symptom recognition 1, 2
- Specify when and how to administer epinephrine 2
3. Medical Identification
4. Adjunctive Medications (2-3 day course)
Important caveat: Evidence supporting corticosteroids and antihistamines for preventing biphasic reactions is weak and contradictory, but they are still commonly prescribed 4
5. Follow-Up Arrangements
- Appointment with primary care provider 1, 4
- Referral to allergist/immunologist for comprehensive evaluation, skin prick testing, and long-term management 2, 4, 6
High-Risk Patient Identification
Patients at highest risk for fatal anaphylaxis include: 1
- Adolescents and young adults 1
- Those with previous anaphylaxis history 1
- Patients with asthma, especially poorly controlled 1, 5
- Known allergy to peanuts, tree nuts, fish, or shellfish 1
All high-risk patients should be prescribed epinephrine autoinjectors even before their first anaphylactic event. 1
Common Pitfalls to Avoid
- Never delay epinephrine while administering antihistamines or other adjunctive treatments—this delay kills patients 1, 2, 6
- Never discharge without observation—death can occur within 30 minutes to 2 hours of exposure 1, 6
- Never prescribe only one autoinjector—approximately 19% of reactions require multiple doses 4, 5
- Never assume mild symptoms will stay mild—progression to severe anaphylaxis can be rapid and unpredictable 1, 6
- Many patients fail to carry or use their autoinjectors despite training due to fear of needles or adverse effects—address these barriers explicitly during education 2, 7